Urinary Modified C-Reactive Protein is Closely Associated with Tubulointerstitial Lesions in Lupus Nephritis

Table 2

Univariate analysis of composite outcomes for patients with lupus nephritis.

Clinicopathological data	HR	95% CI	P value
Age	1.041	(0.987–1.098)	0.142
Sex	0.191	(0.047–0.773)	0.020
SLEDAI	0.992	(0.866–1.137)	0.914
Proteinuria	1.084	(0.986–1.192)	0.096
Hematuria	1.076	(0.129–8.983)	0.946
Leukocyturia	0.905	(0.225–3.646)	0.888
Acute kidney injury	4.544	(1.006–20.525)	0.049
Serum creatinine	1.010	(1.005–1.015)	<0.001
Plasma C3 level	3.273	(0.778–13.767)	0.106
Activity indices score	1.268	(1.014–1.585)	0.037
Chronicity indices score	1.396	(1.091–1.788)	0.008
Plasma mCRP levels	0.979	(0.798–1.201)	0.836
Urinary mCRP levels	1.204	(1.029–1.409)	0.020

HR, hazard ratio; 95% CI, 95% confidence interval; SLEDAI, Systemic Lupus Erythematosus Disease Activity Index; mCRP, modified C reactive protein. Bold values are statistically significant.